Get the Stockscreener App
13.59
0.67%
0.09
After Hours:
13.59
Gh Research Plc stock is traded at $13.59, with a volume of 893.80K.
It is up +0.67% in the last 24 hours and up +3.74% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$13.50
Open:
$13.43
24h Volume:
893.80K
Relative Volume:
3.14
Market Cap:
$707.06M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-17.20
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
-1.31%
1M Performance:
+3.74%
6M Performance:
+21.56%
1Y Performance:
+69.24%
1-Day Range:
$13.11
$13.89
1-Week Range:
$12.50
$14.77
52-Week Range:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
13.59 | 837.40M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.00 | 107.10B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
644.19 | 66.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.56 | 55.95B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
832.35 | 51.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.88 | 38.98B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
Is GH Research PLC stock dividend yield sustainableDollar Strength & Breakout Confirmation Alerts - fcp.pa.gov.br
Is GH Research PLC stock oversold or undervaluedMarket Sentiment Report & Free Technical Confirmation Trade Alerts - newser.com
Understanding GH Research PLC’s price movementPortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
What data driven models say about GH Research PLC’s future2025 Risk Factors & High Win Rate Trade Alerts - newser.com
Will GH Research PLC (1KA) stock see valuation expansionPortfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com
Is GH Research PLC showing signs of accumulationJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
Live market analysis of GH Research PLCJuly 2025 Closing Moves & Safe Entry Point Identification - newser.com
Is GH Research PLC stock a safe buy before earningsWeekly Investment Report & Verified Swing Trading Watchlist - newser.com
Will GH Research PLC stock deliver long term returns2025 Price Momentum & Community Verified Trade Alerts - newser.com
Will breakout in GH Research PLC lead to full recovery2025 Top Gainers & High Conviction Investment Ideas - newser.com
Has GH Research PLC formed a bullish divergence2025 Major Catalysts & High Conviction Trade Alerts - newser.com
What’s next for GH Research PLC stock price2025 AllTime Highs & Technical Analysis for Trade Confirmation - newser.com
Measuring GH Research PLC’s beta against major indicesJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
Will GH Research PLC stock benefit from green energy trendsTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com
Real time alert setup for GH Research PLC performanceProfit Target & Safe Capital Growth Plans - newser.com
Tools to assess GH Research PLC’s risk profile2025 Market Overview & Trade Opportunity Analysis Reports - newser.com
GH Research PLC stock chart pattern explainedDay Trade & AI Powered Market Trend Analysis - newser.com
Is GH Research PLC (1KA) stock considered safe havenPortfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
Historical volatility pattern of GH Research PLC visualizedMarket Growth Review & Free AI Powered Buy and Sell Recommendations - newser.com
Combining machine learning predictions for GH Research PLCWeekly Trend Recap & Technical Confirmation Alerts - newser.com
What momentum shifts mean for GH Research PLCEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
Can GH Research PLC (1KA) stock deliver consistent EPS growthJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Why GH Research PLC stock is favored by pension fundsBull Run & Safe Entry Trade Signal Reports - newser.com
How sustainable is GH Research PLC stock dividend payoutPrice Action & Reliable Entry Point Trade Alerts - newser.com
Why GH Research PLC (1KA) stock remains stable2025 EndofYear Setup & Low Risk High Reward Ideas - newser.com
Why millennials buy GH Research PLC (1KA) stockM&A Rumor & Long-Term Safe Return Strategies - newser.com
GH Research (NASDAQ:GHRS) Trading Up 10.2%Here's What Happened - MarketBeat
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.82%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):